TMAN: T.Man Pharmaceutical Public Company Limited - Summary | Jitta

T.Man Pharmaceutical Public Company Limited

BKK:TMAN

Price
฿10.80
Loss Chance
49.2%
4.88JITTA SCORE
50.30%Over Jitta Line
Jitta Ranking
562 / 839
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (34)
Recent Business Performance (52)
Financial Strength (83)
Return to Shareholders (56)
Competitive Advantage (57)
Jitta Signs
Revenue and EarningConsistent High Growth in the past 5 years
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Recent IPOLess than 3 years
Key Stats
Jitta Score
Jitta Line
4.88
50.30%
5.08
46.77%
4.34
113.73%
Pharmaceuticals
6.25
130.36%
3.66
2.65%
COMPANY DESCRIPTION
T.Man Pharmaceutical Public Company Limited manufactures and sells pharmaceuticals and health care products in Thailand. The company operates through three segments: Manufactured Products Under Own Brand, Manufactured Products Under Third Parties’ Brand, and Trading Products. It offers antibacterial, central nervous system, corticosteroid, chronic diseases, gastrointestinal, respiratory, and musculoskeletal drugs, as well as medical devices, vaginal suppositories, dermatological, mouth, and throat products. The company also provides herbal and traditional medicines, dietary supplements, vitamins and minerals, skin care and aesthetics, whey protein, and mommy and kid products, as well as cosmetics, modern medicines, mossi guard, nevtral, propolis, and vita-c products. In addition, it offers products under various brand names, such as Iyara, Propoliz, POLAR, and Fibermate. The company also exports its products. Further, the company offers original equipment manufacturing services. Additionally, it offers medicines in the form of tablets, capsules, powders, liquids, and semisolids. The company also exports its products. T.Man Pharmaceutical Public Company Limited was founded in 1991 and is based in Bangkok, Thailand.